February 2, 2014
Multiple Sclerosis in Children and Teens, Different Than Adults
- /
By Deborah Mitchell G+ 2014-01-31 06:39 Multiple sclerosis (MS) usually develops in adults, but infrequently the neurodegenerative disease is diagnosed in children…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
February 2, 2014
Advice for People of their Healthcare Team
- /
Written by: Cherie C. Binns RN BS MSCN 10 Things I Advise People re: Their Healthcare Team As an Independent…
February 1, 2014
ENTER the MS Atrium – Rooms of Knowledge
- /
Visit the MS Atrium for content created for you by MS experts. Go to site. Having trouble displaying this email?…
February 1, 2014
Secondary Progressive MS Therapy Natalizumab Being Tested In New Clinical Trial
- /
- /
Posted by: Maureen Newman January 30, 2014 On Monday, I reported on an innovative, new acne bacteria-derived treatment for Secondary Progressive Multiple Sclerosis (SPMS) currently under…
February 1, 2014
Secondary Progressive MS Trial of Lamotrigine Tested For Neuroprotection Benefits
- /
- /
Posted by: Ayesha Khan January 31, 2014 A recently completed study at University College London Hospital suggests that administration of certain drugs…
January 31, 2014
Food poisoning germ may trigger Multiple Sclerosis, study suggests
- /
Mike Szymanski | Multiple Sclerosis Examiner January 29, 2014 Food poisoning could trigger Multiple Sclerosis, according to a just-released research…
January 31, 2014
HIV Drug May Help in PML
- /
- /
Published: Jan 29, 2014 By John Gever, Deputy Managing Editor, MedPage Today A relatively simple way to make progressive multifocal…
January 29, 2014
New Formulation APPROVED of COPAXONE® Offers Patients and Their Physicians Ability to Dose Less Frequently
- /
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved the…
January 28, 2014
Teva and Active Biotech Remain Committed to the Development of NERVENTRA(r) (laquinimod) for Multiple Sclerosis
- /
LUND, Sweden, Jan. 27, 2014 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (TEVA) and Active Biotech (NASDAQ OMX NORDIC: ACTI)…
January 26, 2014
Bladder Issues and other Urologic Dysfunction in Multiple Sclerosis – seminar in Jacksonville, Fl.
- /
- /
- /
CLICK the LINK to REGISTER to attend this program on March 24th, 2014 in Jacksonville, Fl. This is a…
